Tenidap--a new antiarthritic agent.
Tenidap sodium is a novel cytokine inhibitor. Early studies in RA suggest a disease modifying profile as well as providing symptomatic relief. The drug is also effective in OA at a significantly lower dose. The results of clinical trials in RA and OA, which address efficacy and safety, are awaited with interest.
Brooks
P M
PM
University of New South Wales, St. Vincent's Hospital, Darlinghurst, Australia.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology* / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D000078183:Oxindoles
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007211:Indoles; D000078183:Oxindoles; C062866:tenidap